BURT A. ADELMAN - 31 Dec 2023 Form 5 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Burt Adelman
Issuer symbol
VERV
Transactions as of
31 Dec 2023
Net transactions value
$0
Form type
5
Filing time
09 Feb 2024, 17:00:21 UTC
Previous filing
20 Jun 2023
Next filing
28 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Gift $0 -106,200 -26% $0.000000 303,426 07 Nov 2022 Burt A Adelman 2021 GRAT F1, F2
transaction VERV Common Stock Gift $0 +106,200 +568% $0.000000 124,900 07 Nov 2022 Burt A Adelman 2002 Trust F1, F2
transaction VERV Common Stock Gift $0 -266,258 -88% $0.000000 37,168 11 Aug 2023 Burt A Adelman 2021 GRAT F1
transaction VERV Common Stock Gift $0 +266,258 +213% $0.000000 391,158 11 Aug 2023 Burt A Adelman 2002 Trust F1
transaction VERV Common Stock Gift $0 -37,168 -100% $0.000000* 0 18 Sep 2023 Burt A Adelman 2021 GRAT F1
transaction VERV Common Stock Gift $0 +37,168 +9.5% $0.000000 428,326 18 Sep 2023 Burt A Adelman 2002 Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported represent transfers of shares of common stock of the Company from the reporting person's grantor retained annuity trust, of which reporting person is a co-trustee, to reporting person's family trust, of which reporting person is a co-trustee, for estate planning purposes.
F2 The transaction code should read "G5".